Mr Alexander Light is an NIHR Doctoral Fellow and PhD candidate with the Imperial Prostate group. Clinically, he is an ST4 urology registrar within the North West London deanery.
He graduated from Guy's, King's and St Thomas' School of Medical Education in 2019 with Triple Distinction, where he was also awarded a BSc with First Class Honours in Anatomy, Developmental and Human Biology. He subsequently completed the Academic Foundation Programme in Cambridge, conducting prostate cancer research in active surveillance, prognostic modelling, and artificial intelligence. He returned to London in 2021 to start his NIHR Academic Clinical Fellowship under the supervision of Professor Hashim Ahmed and Mr Taimur Shah. He was subsequently awarded a highly-competitive NIHR Doctoral Fellowship in 2024.
Alex's research in Imperial Prostate focuses on enhancing the diagnostic and therapeutic strategies for locally-recurrent prostate cancer after previous radiotherapy or focal therapy using a combination of data science and trial-based approaches. This has included research into imaging modalities like multiparametric MRI and PSMA PET/CT, in addition to subsequent treatment with focal ablation and whole-gland modalities. He is also involved in research in the primary setting, including registry-based studies and the IP6-CHAIROS, IP7-PACIFIC, and IP8-FLUORESCE trials. He has presented work internationally and has been published approximately 50 papers, with first-author work within high-impact journals including European Urology, The Lancet Digital Health, and NPJ Digital Medicine. He has received a number of national and international prizes including the EAU 2024 Best Abstract by a Resident award, the European Urology Impact Award, and the BNMS Young Investigators Prize. He has earnt over £500k in research funding as primary applicant.
Disclosure information not submitted.